Socorro, NM, United States of America

Ivy Hurwitz

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: New Mexico Tech University Research Park Corporation. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ivy Hurwitz: Innovator in Anti-Protozoan Treatments

Introduction

Ivy Hurwitz is a notable inventor based in Socorro, NM (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with anti-protozoan activity. Her work focuses on innovative methods for treating parasitic infections, which can have a profound impact on public health.

Latest Patents

Ivy Hurwitz holds 1 patent for her invention titled "Small molecules with anti-protozoan activity." This patent describes a method of treating infections, including parasitic infections, using specific compounds that can selectively eradicate intracellular mammalian and human parasites. This advancement represents a crucial step forward in the fight against parasitic diseases.

Career Highlights

Ivy is affiliated with the New Mexico Tech University Research Park Corporation, where she continues her research and development efforts. Her work is characterized by a commitment to innovation and a focus on practical applications that can benefit society.

Collaborations

Ivy collaborates with talented individuals such as Snezna Rogelj and Danielle Nicole Turner. These partnerships enhance her research capabilities and contribute to the advancement of her projects.

Conclusion

Ivy Hurwitz is a pioneering inventor whose work in anti-protozoan treatments showcases her dedication to improving health outcomes. Her innovative approach and collaboration with fellow researchers position her as a key figure in the field of medicinal chemistry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…